DOI: 10.1007/s00259-017-3781-6Pages: 1-2

Visualization of HER2-specific breast cancer intratumoral heterogeneity using 64Cu-DOTA-trastuzumab PET

1. National Cancer Center Hospital, Department of Breast and Medical Oncology

2. Hiroshima University, Surgical Oncology, Research Institute for Radiation Biology and Medicine

3. National Cancer Center Hospital, Department of Diagnostic Radiology

4. National Cancer Center Hospital, Department of Breast Surgery

5. National Cancer Center Hospital, Department of Pathology and Clinical Laboratories

6. National Cancer Center Research Institute, Division of Molecular Pharmacology and Pharmacokinetics

7. RIKEN Center for Life Science Technologies

Correspondence to:
Kenji Tamura
Tel: +81-3-3542-2511
Email: ketamura@ncc.go.jp

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

  • Accepted: Jul 13, 2017
  • Online: Aug 3, 2017

Article Tools

eanm
EJNMMI Ad